O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor α Expression and Confer Resistance to 4-OH-Tamoxifen in Human Breast Cancer-Derived MCF-7 Cells
出版年份 2013 全文链接
标题
O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor α Expression and Confer Resistance to 4-OH-Tamoxifen in Human Breast Cancer-Derived MCF-7 Cells
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 7, Pages e69150
出版商
Public Library of Science (PLoS)
发表日期
2013-07-12
DOI
10.1371/journal.pone.0069150
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Critical Role ofO-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis
- (2012) Thomas P. Lynch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2
- (2012) Cécile Pierre-Eugene et al. PLoS One
- Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection
- (2012) Kevin A. Kwei et al. PLoS One
- The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation
- (2011) Stéphanie Olivier-Van Stichelen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy
- (2011) Wenyi Mi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Gene expression of O-GlcNAc cycling enzymes in human breast cancers
- (2011) Anna Krześlak et al. CLINICAL AND EXPERIMENTAL MEDICINE
- A New Highly Efficient Substrate-trapping Mutant of Protein Tyrosine Phosphatase 1B (PTP1B) Reveals Full Autoactivation of the Insulin Receptor Precursor
- (2011) Samira Boubekeur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer
- (2011) Chungyeul Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation
- (2011) Qianqian Zhu et al. MEDICAL ONCOLOGY
- O-GlcNAc inhibits interaction between Sp1 and sterol regulatory element binding protein 2
- (2010) Kihong Lim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Elevated O-LinkedN-Acetylglucosamine Correlated with Reduced Sp1 Cooperative DNA Binding with Its Collaborating Factorsin Vivo
- (2010) Kihong LIM et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- GlcNAcylation Plays an Essential Role in Breast Cancer Metastasis
- (2010) Y. Gu et al. CANCER RESEARCH
- O-GlcNAc modification, insulin signaling and diabetic complications
- (2010) T. Issad et al. DIABETES & METABOLISM
- Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1
- (2010) S A Caldwell et al. ONCOGENE
- O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y
- (2009) Kihong Lim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Implication of protein tyrosine phosphatase 1B in MCF-7 cell proliferation and resistance to 4-OH tamoxifen
- (2009) Christophe Blanquart et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- O-GlcNAc inhibits interaction between Sp1 and Elf-1 transcription factors
- (2009) Kihong Lim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease
- (2009) Tony Lefebvre et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells
- (2009) A Madeo et al. ONCOGENE
- Regulation of Akt signaling by O-GlcNAc in euglycemia
- (2008) Yudi A. Soesanto et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Nutrition, metabolic factors and cancer risk
- (2008) Laure Dossus et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer
- (2008) Christophe Blanquart et al. BIOCHEMICAL PHARMACOLOGY
- O-GlcNAc modification of FoxO1 increases its transcriptional activity: A role in the glucotoxicity phenomenon?
- (2008) MeiShiue Kuo et al. BIOCHIMIE
- Rational management of endocrine resistance in breast cancer
- (2008) Sara A. Hurvitz et al. CANCER
- Glucose avidity of carcinomas
- (2008) Álvaro D. Ortega et al. CANCER LETTERS
- O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1
- (2008) Kihong Lim et al. FEBS LETTERS
- O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene
- (2008) MeiShiue Kuo et al. FEBS LETTERS
- Insulin resistance, obesity and breast cancer risk
- (2008) C. Pichard et al. MATURITAS
- Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance
- (2008) Xiaoyong Yang et al. NATURE
- O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity
- (2008) Tarik Issad et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started